Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
Total Valuation
Ginkgo Bioworks Holdings has a market cap or net worth of $835.84M. The enterprise value is $218.87M.
Market Cap$835.84M
Enterprise Value$218.87M
Share Statistics
Ginkgo Bioworks Holdings has 46,344,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,344,630
Owned by Insiders1.09%
Owned by Institutions2.36%
Financial Efficiency
Ginkgo Bioworks Holdings’s return on equity (ROE) is -0.76 and return on invested capital (ROIC) is -43.05%.
Return on Equity (ROE)-0.76
Return on Assets (ROA)-0.40
Return on Invested Capital (ROIC)-43.05%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee272.23K
Profits Per Employee-655.91K
Employee Count834
Asset Turnover0.16
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Ginkgo Bioworks Holdings is ―. Ginkgo Bioworks Holdings’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.71
Price to FCF0.00
Price to Operating Cash Flow-1.83
PEG Ratio―
Income Statement
In the last 12 months, Ginkgo Bioworks Holdings had revenue of 227.04M and earned -547.03M in profits. Earnings per share was -10.54.
Revenue227.04M
Gross Profit188.49M
Operating Income-559.76M
Pretax Income-547.51M
Net Income-547.03M
EBITDA-484.39M
Earnings Per Share (EPS)-10.54
Cash Flow
In the last 12 months, operating cash flow was -281.85M and capital expenditures -63.45M, giving a free cash flow of -345.30M billion.
Operating Cash Flow-281.85M
Free Cash Flow-345.30M
Free Cash Flow per Share-7.45
Dividends & Yields
Ginkgo Bioworks Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.01
52-Week Price Change17.76%
50-Day Moving Average10.46
200-Day Moving Average9.33
Relative Strength Index (RSI)58.14
Average Volume (3m)1.80M
Important Dates
Ginkgo Bioworks Holdings upcoming earnings date is Nov 17, 2025, After Close (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date―
Financial Position
Ginkgo Bioworks Holdings as a current ratio of 5.62, with Debt / Equity ratio of 67.12%
Current Ratio5.62
Quick Ratio5.62
Debt to Market Cap0.00
Net Debt to EBITDA0.19
Interest Coverage Ratio-5.95K
Taxes
In the past 12 months, Ginkgo Bioworks Holdings has paid -479.00K in taxes.
Income Tax-479.00K
Effective Tax Rate<0.01
Enterprise Valuation
Ginkgo Bioworks Holdings EV to EBITDA ratio is -0.86, with an EV/FCF ratio of -1.09.
EV to Sales1.83
EV to EBITDA-0.86
EV to Free Cash Flow-1.09
EV to Operating Cash Flow-1.30
Balance Sheet
Ginkgo Bioworks Holdings has $516.92M in cash and marketable securities with $434.56M in debt, giving a net cash position of -$82.36M billion.
Cash & Marketable Securities$516.92M
Total Debt$434.56M
Net Cash-$82.36M
Net Cash Per Share-$1.78
Tangible Book Value Per Share$12.40
Margins
Gross margin is 73.59%, with operating margin of -246.54%, and net profit margin of -240.94%.
Gross Margin73.59%
Operating Margin-246.54%
Pretax Margin-241.15%
Net Profit Margin-240.94%
EBITDA Margin-213.35%
EBIT Margin-241.11%
Analyst Forecast
The average price target for Ginkgo Bioworks Holdings is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$10.00
Price Target Upside-25.71% Downside
Analyst ConsensusModerate Sell
Analyst Count5
Revenue Growth Forecast13.76%
EPS Growth Forecast48.34%